newsfilter
← Latest News
Business Wire·

TherapeuticsMD Announces Appointment of Mark Glickman as Chief Business Officer

TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative, leading women's healthcare company, today announced the appointment of Mark Glickman as the Company's Chief Business Officer. Mr. Glickman previously served as Chief Commercial Officer of Esperion an